Company Filing History:
1 out of 371 
1 out of 9 
Years Active: 2021
Title: Marcel Nold: Innovator in Anti-Inflammatory Therapeutics
Introduction
Marcel Nold is a prominent inventor based in Clayton, Australia. He is known for his significant contributions to the field of anti-inflammatory therapeutics. His work focuses on the development of innovative polypeptides that have the potential to treat various inflammatory diseases.
Latest Patents
Marcel Nold holds a patent for IL-37 variants. This invention relates to polypeptides, including variants of interleukin-37 (IL-37), and related therapeutics and compositions. The invention also encompasses the use of these polypeptides and compositions in methods of treating inflammatory diseases or conditions. The present invention provides a monomeric anti-inflammatory polypeptide comprising an amino acid sequence of an IL-37 monomer, with modifications to prevent the anti-inflammatory peptide from forming a homodimer. He has 1 patent to his name.
Career Highlights
Throughout his career, Marcel Nold has worked with notable institutions, including Beijing University of Technology and the Hudson Institute of Medical Research. His research has significantly advanced the understanding of anti-inflammatory mechanisms and therapeutic applications.
Collaborations
Marcel has collaborated with several professionals in his field, including Claudia Nold and Andrew Ellisdon. These collaborations have contributed to the development of his innovative therapeutic approaches.
Conclusion
Marcel Nold's work in the field of anti-inflammatory therapeutics showcases his dedication to innovation and research. His patented IL-37 variants represent a significant advancement in treating inflammatory diseases.